Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum

A. Bates, Timothy; C. Leier, Hans; L. Lyski, Zoë; K. McBride, Savannah; J. Coulter, Felicity; B. Weinstein, Jules; R. Goodman, James; Lu, Zhengchun; Siegel, Sarah; Sullivan, Peter; Strnad, Matt; E. Brunton, Amanda; X. Lee, David; Adey, Andrew; N. Bimber, Benjamin; J. O’Roak, Brian; E. Curlin, Marcel; B. Messer, William; Tafesse, Fikadu

doi:10.1038/s41467-021-25479-6

Public

Neutralization of SARS-CoV-2 variants by convalescent and BNT162b2 vaccinated serum

Published in Nature Communications • Aug 26, 2021

Authors:

Timothy A. Bates

Hans C. Leier

Zoë L. Lyski

Abstract

SARS-CoV-2 and its variants continue to infect hundreds of thousands every day despite the rollout of effective vaccines. Therefore, it is essential to understand the levels of protection that these vaccines provide in the face of emerging variants. Here, we report two demographically balanced cohor...

Subject

Neutralization

Virology

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)

Research Assistant

AI chat, annotations, notes & similar papers

Finding related papers...

Discussions

(0)

No comments yet

Be the first to share your thoughts!